| Ms Dayna K Willbanks, OTR/L | |
|
106 E 3rd St, Moscow, ID 83843-2970 | |
| (509) 432-1575 | |
| (509) 332-8045 |
| Full Name | Ms Dayna K Willbanks |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 106 E 3rd St, Moscow, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841340486 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | OT406 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Dayna K Willbanks, OTR/L 455 Nw Robert St, Pullman, WA 99163-3640 Ph: (509) 432-1575 | Ms Dayna K Willbanks, OTR/L 106 E 3rd St, Moscow, ID 83843-2970 Ph: (509) 432-1575 |
News Archive
Our ancestors evolutionarily split from those of rhesus monkeys about 25 million years ago. Since then, brain areas have been added, have disappeared or have changed in function. This raises the question, 'Has evolution given humans unique brain structures?'. Scientists have entertained the idea before but conclusive evidence was lacking. By combining different research methods, we now have a first piece of evidence that could prove that humans have unique cortical brain networks.
Guidelines and training for doctors have tried to address the problems they face when dealing with patients who come from cultures and ethnic groups different to their own.
Magen BioSciences, Inc., a privately held specialty pharmaceutical company focused on developing pharmaceuticals to treat diseases of the skin, announced today that it had acquired the rights to a series of novel pre-clinical compounds from Eli Lilly and Company.
One group of neurons controls various types of sighing, but they receive their instructions from different areas of the brain depending on the reason for the sigh, according to a study scheduled to publish June 16 in the journal Cell Reports.
A recent, updated predictive analysis of the three WHO-defined molecular subgroups based on isocitrate dehydrogenase 1/2 (IDH) mutation status and 1p/19q co-deletion status represented in the high-risk treatment arms of the NRG Oncology clinical trial NRG-RTOG 9802 indicates that both IDH-mutant sub-groups (IDHmut-noncodel and IDHmut-codel) could benefit from the addition of PCV chemotherapy to radiotherapy treatment.
› Verified 9 days ago
Jill Peterson, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 914 S Jefferson St, Apt. 1, Moscow, ID 83843 Phone: 701-430-4013 | |
Moriah Eagle, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1350 Troy Rd, Moscow, ID 83843 Phone: 877-456-1233 | |
Anita Evans, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 420 Rowe St, Moscow, ID 83843 Phone: 208-882-4576 | |
Mrs. Barbara Anne Mahoney, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 225 E Palouse River Dr, Moscow, ID 83843 Phone: 208-883-6483 Fax: 208-883-6489 | |
Mrs. Frances Anne Preston, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 640 N Eisenhower St, Moscow, ID 83843 Phone: 208-882-6560 | |
Jenifer Ann Howerton, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 420 Rowe St, Moscow, ID 83843 Phone: 208-882-4576 Fax: 208-892-8776 | |
Nancy Jane Akin, O.T.R./L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 872 Troy Rd, Moscow, ID 83843 Phone: 208-892-8888 Fax: 208-882-8890 |